HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Masura, J. Articles by Podnar, T. Search for Related Content PubMed PubMed Citation Articles by Masura, J. Articles by Podnar, T.

CLINICAL RESEARCH: MINI-FOCUS: TRANSCATHETER CLOSURE OF ASD AND PFO

Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders

Jozef Masura, MD, PhD, Pavol Gavora, MD and Toma Podnar, MD, PhD^*

Children's Cardiac Center, University Children's Hospital, Bratislava, Slovakia

Manuscript received June 3, 2004; revised manuscript received September 13, 2004, accepted October 25, 2004.

^* Reprint requests and correspondence: Dr. Toma Podnar, University Children's Hospital, University Medical Center, Vrazov trg 1, 1525 Ljubljana, Slovenia (Email: tomaz.podnar{at}mf.uni-lj.si).

OBJECTIVES: The aim of this study was to assess long-term results of percutaneous closure of secundum-type atrial septal defect (ASD II) using Amplatzer septal occluders (ASO).

BACKGROUND: Only immediate-, short-, and intermediate-term results of ASO implantation are known so far.

METHODS: Between September 1995 and January 2000, 151 patients underwent a successful percutaneous closure of ASD II in our institution. All were included in the present study and were followed up until September 2004.

RESULTS: This group of patients was followed up from 56 to 108 months (median 78 months). The mean stretched defect diameter was 15.9 ± 4.8 mm. There were no deaths or significant complications during the study. At three years of follow-up, all defects were completely closed and remained closed thereafter.

CONCLUSIONS: Since the first human implantations in September 1995, the Amplatzer septal occluder proved as a safe and effective device for percutaneous closure of ASD II.

Abbreviations and Acronyms   ASD II = secundum-type atrial septal defect   ASO = Amplatzer septal occluder   TEE = transesophageal echocardiography   TTE = transthoracic echocardiography

This article has been cited by other articles:

				L. E.J. Thomson, A. L. Crowley, J. F. Heitner, P. J. Cawley, J. W. Weinsaft, H. W. Kim, M. Parker, R. M. Judd, J. K. Harrison, and R. J. Kim Direct En Face Imaging of Secundum Atrial Septal Defects by Velocity-Encoded Cardiovascular Magnetic Resonance in Patients Evaluated for Possible Transcatheter Closure Circ Cardiovasc Imaging, July 1, 2008; 1(1): 31 - 40. [Abstract] [Full Text] [PDF]

				G.J. Morgan, F. Casey, B. Craig, and A. Sands Assessing ASDs prior to device closure using 3D echocardiography. Just pretty pictures or a useful clinical tool? Eur J Echocardiogr, July 1, 2008; 9(4): 478 - 482. [Abstract] [Full Text] [PDF]

				L. Morgenstern The decline and fall of the surgical incision. Surgical Innovation, September 1, 2006; 13(3): 207 - 208. [PDF]

				I. A. Russell, K. Rouine-Rapp, G. Stratmann, and W. C. Miller-Hance Congenital heart disease in the adult: a review with internet-accessible transesophageal echocardiographic images. Anesth. Analg., March 1, 2006; 102(3): 694 - 723. [Full Text] [PDF]

				A. N. DeMaria, O. Ben-Yehuda, D. Berman, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, W. Y.W. Lew, D. Sahn, and S. Tsimikas Highlights of the Year in JACC 2005 J. Am. Coll. Cardiol., January 3, 2006; 47(1): 184 - 202. [Full Text] [PDF]